Literature DB >> 32056199

Virtual Twins: Understanding the Data Required for Model-Informed Precision Dosing.

Thomas M Polasek1,2,3, Amin Rostami-Hodjegan1,4.   

Abstract

Year:  2020        PMID： 32056199     DOI： 10.1002/cpt.1778

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

Review 1.  The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry Perspectives.

Authors:  Om Anand; Xavier J H Pepin; Vidula Kolhatkar; Paul Seo
Journal:  Pharm Res       Date:  2022-05-18       Impact factor: 4.580

2.  Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition.

Authors:  Chie Emoto; Trevor N Johnson; Takaaki Yamada; Hiroshi Yamazaki; Tsuyoshi Fukuda
Journal:  Eur J Clin Pharmacol       Date:  2021-02-01       Impact factor: 2.953

3.  Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing.

Authors:  Warit Ruanglertboon; Michael J Sorich; Ashley M Hopkins; Andrew Rowland
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-21

Review 4.  Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm.

Authors:  Vijayalakshmi Chelliah; Georgia Lazarou; Sumit Bhatnagar; John P Gibbs; Marjoleen Nijsen; Avijit Ray; Brian Stoll; R Adam Thompson; Abhishek Gulati; Serguei Soukharev; Akihiro Yamada; Jared Weddell; Hiroyuki Sayama; Masayo Oishi; Sabine Wittemer-Rump; Chirag Patel; Christoph Niederalt; Rolf Burghaus; Christian Scheerans; Jörg Lippert; Senthil Kabilan; Irina Kareva; Natalya Belousova; Alex Rolfe; Anup Zutshi; Marylore Chenel; Filippo Venezia; Sylvain Fouliard; Heike Oberwittler; Alix Scholer-Dahirel; Helene Lelievre; Dean Bottino; Sabrina C Collins; Hoa Q Nguyen; Haiqing Wang; Tomoki Yoneyama; Andy Z X Zhu; Piet H van der Graaf; Andrzej M Kierzek
Journal:  Clin Pharmacol Ther       Date:  2020-08-14       Impact factor: 6.875

Review 5.  Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.

Authors:  Craig R Rayner; Patrick F Smith; David Andes; Kayla Andrews; Hartmut Derendorf; Lena E Friberg; Debra Hanna; Alex Lepak; Edward Mills; Thomas M Polasek; Jason A Roberts; Virna Schuck; Mark J Shelton; David Wesche; Karen Rowland-Yeo
Journal:  Clin Pharmacol Ther       Date:  2021-03-09       Impact factor: 6.875

6.  Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities.

Authors:  Brahim Achour; Pauline Gosselin; Amin Rostami-Hodjegan; Jean-Luc Reny; Jean Terrier; Yvonne Gloor; Zubida M Al-Majdoub; Thomas M Polasek; Youssef Daali
Journal:  Clin Pharmacol Ther       Date:  2022-03-28       Impact factor: 6.903

7.  Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessment.

Authors:  Rebekka Fendt; Ute Hofmann; Annika R P Schneider; Elke Schaeffeler; Rolf Burghaus; Ali Yilmaz; Lars Mathias Blank; Reinhold Kerb; Jörg Lippert; Jan-Frederik Schlender; Matthias Schwab; Lars Kuepfer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.